Nanobiotix S.A.

Biotechnology • Healthcare • Paris, France • NBTX (NMS)

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.

33 1 40 26 04 70 60 rue de Wattignies, France

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Nanobiotix (NASDAQ:NBTX) Shares Gap Down - Time to Sell? - MarketBeat

MarketBeat • Jan 6

Nanobiotix S.A.: Behind The Recent Momentum (NASDAQ:NBTX) - Seeking Alpha

Seeking Alpha • Oct 23

Nanobiotix (NASDAQ:NBTX) Stock Price Down 6.2% - Here's What Happened - MarketBeat

MarketBeat • Jan 5

Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue - The Motley Fool

The Motley Fool • Nov 24

symbol__ Stock Quote Price and Forecast - CNN

CNN • May 7

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Nanobiotix S.A. had layoffs?

No layoff events have been recorded for Nanobiotix S.A. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Nanobiotix S.A. have?

Nanobiotix S.A. has approximately 103 employees.

What industry is Nanobiotix S.A. in?

Nanobiotix S.A. operates in the Biotechnology industry, within the Healthcare sector.

Is Nanobiotix S.A. a publicly traded company?

Yes, Nanobiotix S.A. is publicly traded under the ticker symbol NBTX on the NMS. The company has a market capitalization of approximately $1.09 billion.

Where is Nanobiotix S.A. headquartered?

Nanobiotix S.A. is headquartered in Paris, France at 60 rue de Wattignies, France.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.